Literature DB >> 18434650

Eliminating blinding trachoma.

Joseph A Cook1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18434650     DOI： 10.1056/NEJMp0708546

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  11 in total

1.  Community mass treatment with azithromycin for trachoma: Factors associated with change in participation of children from the first to the second round.

Authors:  Elizabeth N Ssemanda; Harran Mkocha; Joshua Levens; Beatriz Munoz; Sheila K West
Journal:  Clin Epidemiol Glob Health       Date:  2015-04

2.  The etiology of infectious corneal ulceration in Sierra Leone.

Authors:  J A Capriotti; J S Pelletier; M Shah; D M Caivano; P Turay; D C Ritterband
Journal:  Int Ophthalmol       Date:  2010-01-29       Impact factor: 2.031

3.  Geospatial distribution and clustering of Chlamydia trachomatis in communities undergoing mass azithromycin treatment.

Authors:  Jithin Yohannan; Bing He; Jiangxia Wang; Gregory Greene; Yvette Schein; Harran Mkocha; Beatriz Munoz; Thomas C Quinn; Charlotte Gaydos; Sheila K West
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-06-06       Impact factor: 4.799

4.  Mass treatment with azithromycin for trachoma control: participation clusters in households.

Authors:  Elizabeth N Ssemanda; Beatriz Munoz; Emma M Harding-Esch; Tansy Edwards; Harran Mkocha; Robin L Bailey; Ansumana Sillah; Dianne Stare; David C W Mabey; Sheila K West
Journal:  PLoS Negl Trop Dis       Date:  2010-10-05

5.  Sanitation and health.

Authors:  Duncan Mara; Jon Lane; Beth Scott; David Trouba
Journal:  PLoS Med       Date:  2010-11-16       Impact factor: 11.069

6.  Can we stop mass drug administration prior to 3 annual rounds in communities with low prevalence of trachoma?: PRET Ziada trial results.

Authors:  Jithin Yohannan; Beatriz Munoz; Harran Mkocha; Charlotte A Gaydos; Robin Bailey; Thomas A Lietman; Thomas Quinn; Sheila K West
Journal:  JAMA Ophthalmol       Date:  2013-04       Impact factor: 7.389

7.  Azithromycin mass treatment for trachoma control: risk factors for non-participation of children in two treatment rounds.

Authors:  Elizabeth N Ssemanda; Joshua Levens; Harran Mkocha; Beatriz Munoz; Sheila K West
Journal:  PLoS Negl Trop Dis       Date:  2012-03-20

8.  Survey, Culture, and Genome Analysis of Ocular Chlamydia trachomatis in Tibetan Boarding Primary Schools in Qinghai Province, China.

Authors:  Le Feng; Xinxin Lu; Yonghui Yu; Tao Wang; Shengdong Luo; Zhihui Sun; Qing Duan; Ningli Wang; Lihua Song
Journal:  Front Cell Infect Microbiol       Date:  2017-01-09       Impact factor: 5.293

9.  Independent inactivation of arginine decarboxylase genes by nonsense and missense mutations led to pseudogene formation in Chlamydia trachomatis serovar L2 and D strains.

Authors:  Teresa N Giles; Derek J Fisher; David E Graham
Journal:  BMC Evol Biol       Date:  2009-07-16       Impact factor: 3.260

10.  Direct amplification, sequencing and profiling of Chlamydia trachomatis strains in single and mixed infection clinical samples.

Authors:  Sandeep J Joseph; Ben Li; Tanvi Ghonasgi; Chad P Haase; Zhaohui S Qin; Deborah Dean; Timothy D Read
Journal:  PLoS One       Date:  2014-06-27       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.